The Effects of Radiotherapy on the Quality of Life in Localized Prostate Cancer Patients

被引:0
作者
Guler Avci, Gulhan [1 ]
Yucel, Birsen [2 ]
Erdis, Eda [2 ]
机构
[1] Univ Gaziosmanpasa, Dept Radiat Oncol, Fac Med, Tokat, Turkey
[2] Univ Cumhuriyet, Dept Radiat Oncol, Fac Med, Sivas, Turkey
来源
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY | 2020年 / 35卷 / 03期
关键词
Prostate cancer; quality of life; radiotherapy; INTENSITY-MODULATED RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; DOSE-RESPONSE; EORTC; QUESTIONNAIRE; TOXICITY; QLQ-C30; GY;
D O I
10.5505/tjo.2020.2240
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVE The present study aims to investigate the radiation-related toxicity and its effects on the quality of life in patients with prostate cancer who received definitive or adjuvant radiotherapy (RT). METHODS Eighty-seven localized prostate cancer patients who underwent RT between January 2011 and June 2016 were enrolled. Each patient filled the EORTC QLQC30 and QLQ-P1225 at four different times (starting and ending at RT, one and six months after RT). EORTC QLQ-C30 questionnaire consists of global health status, five functional (physical, role, cognitive, emotional, social) and nine symptom scales (fatigue nausea/vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea and financial difficulties). EORTC QLQ-PR25 consists of two functional (sexual activity and sexual functioning) and four symptom scales (urinary, bowel, hormonal treatment-related, incontinence aid). RESULTS According to the EORTC QLQ-C30 questionnaire, global health status score (p=0.007), emotional score (p=0.016), fatigue (p=0.004) and diarrhea score (p=0.003); according to EORTC QLQPR25 questionnaire, urinary score (p=0.024) were significantly poorer at the end of RT. When patients' quality of life questionnaires were compared concerning treatment type (definitive vs. adjuvant RT), RT technique (31) CRT vs. IMRT) and RT field (prostate/prostate+seminal vesicle vs. prostate+ seminal vesicleipelvic lymph node); EORTC QLQ C-30 and EORTC QLQ PR-25 functional and symptom scales were not different between groups. CONCLUSION The RT approach in prostate cancer produced temporary impairment in some scores of QLQ, but all these scores showed improvement from the first month after RT.
引用
收藏
页码:242 / 249
页数:8
相关论文
共 50 条
  • [21] Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: The Triumph of Radiobiology
    Kougioumtzopoulou, Andromachi
    Platoni, Kalliopi
    Zygogianni, Anna
    Kounadis, George
    Syrigos, Konstantinos N.
    Psyrri, Adamantia
    Bamias, Aristotelis
    Kelekis, Nikolaos
    Kouloulias, Vasileios
    REVIEWS ON RECENT CLINICAL TRIALS, 2021, 16 (04) : 351 - 371
  • [22] Localized prostate cancer in older patients: Radical prostatectomy or radiotherapy versus observation
    Petrelli, Fausto
    Dottorini, Lorenzo
    De Stefani, Agostina
    Vavassori, Ivano
    Luciani, Andrea
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (06)
  • [23] Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer
    Hu, Wei
    Pei, Yulei
    Ning, Renli
    Li, Ping
    Zhang, Zhenshan
    Hong, Zhengshan
    Bao, Cihang
    Guo, Xiaomao
    Sun, Yun
    Zhang, Qing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 4533 - 4545
  • [24] No impairment of quality of life after radiotherapy for prostate cancer
    Meier, Maria M.
    Koelbl, Oliver
    Gruber, Isabella
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [25] The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial
    Alexidis, Petros
    Dragoumis, Dimitris
    Karatzoglou, Sotirios
    Drevelegas, Konstantinos
    Tzitzikas, Ioannis
    Hatzimouratidis, Konstantinos
    Chrisogonidis, Ioannis
    Giannakidis, Dimitris
    Koulouris, Charilaos
    Katsaounis, Athanasios
    Michalopoulos, Nikolaos
    Huang, Haidong
    Li, Qiang
    Aidoini, Zoi
    Fyntanidou, Varbara
    Amaniti, Aikaterini
    Hohenforst-Schmidt, Wolfgang
    Maragouli, Elena
    Petanidis, Savvas
    Zarogoulidis, Paul
    Sapalidis, Konstantinos
    Kosmidis, Christoforos
    Romanidis, Konstantinos
    Oinkonomou, Panagoula
    Vagionas, Anastasios
    Nikolaos-Katsios, Iason
    Ioannidis, Aris
    Boniou, Konstantina
    Kesisoglou, Isaak
    JOURNAL OF CANCER, 2019, 10 (25): : 6217 - 6224
  • [26] Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
    Lazo, Antonio
    de la Torre-Luque, Alejandro
    Arregui, Gregorio
    Rivas, Daniel
    Serradilla, Ana
    Gomez, Joaquin
    Jurado, Francisca
    Isabel Nunez, Maria
    Lopez, Escarlata
    BIOLOGY-BASEL, 2022, 11 (03):
  • [27] Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer
    Maruyama, Katsuya
    Tsuji, Hiroshi
    Nomiya, Takuma
    Katoh, Hiroyuki
    Ishikawa, Hitoshi
    Kamada, Tadashi
    Wakatsuki, Masaru
    Akakura, Koichiro
    Shimazaki, Jun
    Aoyama, Hidefumi
    Tsujii, Hirohiko
    JOURNAL OF RADIATION RESEARCH, 2017, 58 (02) : 260 - 266
  • [28] Development of indicators of the quality of radiotherapy for localized prostate cancer
    Danielson, Brita
    Brundage, Michael
    Pearcey, Robert
    Bass, Brenda
    Pickles, Tom
    Bahary, Jean-Paul
    Foley, Kimberley
    Mackillop, William
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 (01) : 29 - 36
  • [29] A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer Quality of Life Outcomes
    Robinson, John W.
    Donnelly, Bryan J.
    Siever, Jodi E.
    Saliken, John C.
    Ernst, Scott D.
    Rewcastle, John C.
    Trpkov, Kiril
    Lau, Harold
    Scott, Cheryl
    Thomas, Bejoy
    CANCER, 2009, 115 (20) : 4695 - 4704
  • [30] Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?
    Parker, Walter R.
    Montgomery, Jeffery S.
    Wood, David P., Jr.
    CURRENT OPINION IN UROLOGY, 2009, 19 (03) : 303 - 308